{"id":381051,"date":"2020-11-13T14:46:32","date_gmt":"2020-11-13T19:46:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381051"},"modified":"2020-11-13T14:46:32","modified_gmt":"2020-11-13T19:46:32","slug":"agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/","title":{"rendered":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LEXINGTON, Mass., Nov.  13, 2020  (GLOBE NEWSWIRE) &#8212; \u00a0Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Dr. Dhan Chand, Scientific Director Head of Drug Discovery at Agenus, will participate in a webcast hosted by Dr. Matt Phipps of William Blair on Monday, November 16, 2020 at 10:00 a.m. ET.<\/p>\n<p>Dr. Steven O\u2019Day will review data of AGEN1181 from its ongoing Ph1 dose escalation trial and discuss the initial responses, particularly those in patients with microsatellite stable disease, and how to place these data in context with other CTLA-4 antibodies. He will also discuss the potential implications of demonstrated Treg depletion with AGEN1181.<\/p>\n<p>Dr. Jennifer Buell and Dr. Dhan Chand of Agenus will be available to discuss the next steps for AGEN1181 and indications selected for expansion. They will also discuss data from other programs presented at SITC, including first clinical data for AGEN2373, a CD137 agonist, the demonstrated importance of Fc-enhancement for TIGIT, and preclinical data for AgenT-797, AgenTus\u2019 iNKT cell therapy, which recently entered the clinic for COVID-19.<\/p>\n<p>Registration for the webinar can be done in advance at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aAxxr5622D3-VFr8pyijEGi6lL5j_AS5fobqA_96HWUlec6jN_Z4R3IUYdPqGyzJ_11Fk9gZC_qqSyU9HdhhMy2qUSUxiXpZsJ6rTkbPQI192uV0Fu5yn4I1tIN2gUH4YOG_eguIzernUBZSzqgUx8E-PITt_W3uH-QdRsG4tgxbmB5OnckNApanUyIE-KlV2PCDNkAsT-BZG7k6aINNoLXx3P8_lAIKRu-StMmFX6s=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/williamblair.zoom.us\/webinar\/register\/WN_b0mxF_6yTWaC3bOTmfiTig<\/a>.<\/p>\n<p>A replay will be available after the call on the Events &amp; Presentations page of the Agenus website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aAxxr5622D3-VFr8pyijEDN3PEI-3ymG-WGgmBe-G0p_euShII75hGHhMqZzImInyzjLz9RS0V3x7Xq_9iLD-2wSxUjBPe_8wnYE9Fx2rQBQ5oAS2FPTVrIWtVE7OCM5cW5Ivs9u2S1PNT1SYHx0YBDrbFm9Yx74tACvRUHf4dggs7L1mNiyQYtVMc2URLkI\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/investor.agenusbio.com\/events-and-presentations<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>About Agenus<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body&#8217;s immune system to fight cancer. The Company&#8217;s vision is to expand the patient populations benefiting from cancer immunotherapy by pursuing combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through its AgenTus Therapeutics subsidiary), and proprietary cancer vaccine platforms. The Company is equipped with a suite of antibody discovery platforms and a state-of-the-art GMP manufacturing facility with the capacity to support clinical programs. Agenus is headquartered in\u00a0Lexington, MA.\u00a0For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pXJAVy7ukDO0go-CnFfZ3rSvHxsaDxv1RLTmOB7Ei38GRYDSyXSFPY-n3_rLIIBccCRvd-2kL_T0436M8TGBSSfGgkGK1YnTbbw7FPvZ4Ywpn-m5SaGOkyszc9HN5A7ixg3_nRHtlj6frvpisFvwpKGizrDNrmzXNsTkJPJITRMTflsuMli3-d8KQpzJ9mPSU5IrTbuFpBON7kAC_j0ydQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.agenusbio.com<\/a>\u00a0and our Twitter handle @agenus_bio. Information that may be important to investors will be routinely posted on our website and Twitter.<\/p>\n<p>\n        <strong><br \/>\n          <u>Forward-Looking Statements<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding the potential and anticipated next steps for Agenus\u2019 AGEN1181, AGEN2373, anti-TIGIT, and AgenT-797, as well as the rest of its other pipeline assets. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among others, the factors described under the Risk Factors section of our most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission. Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and Agenus undertakes no obligation to update or revise the statements, other than to the extent required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.<\/p>\n<p>\n        <strong><br \/>\n          <u>Contact:<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Agenus Inc.<\/strong><br \/>\n        <br \/>Caroline Bafundo <br \/>212-994-8209<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8aMpikeULl70LLqru4CAkB3IlKguoXVZgzp3zsR-BZB9IB8cbXQd1yCO203DaJP66QkXVoApdkPpK-j5ILdp2y2cmrGJmg8WMW3B5JdpoJmdzqt9ZBbldiYTwg9p9wdK\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Caroline.Bafundo@agenusbio.com<\/a>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/bb1d9969-5211-4936-a69f-6567d1657c1b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; \u00a0Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Dr. Dhan Chand, Scientific Director Head of Drug Discovery at Agenus, will participate in a webcast hosted by Dr. Matt Phipps of William Blair on Monday, November 16, 2020 at 10:00 a.m. ET. Dr. Steven O\u2019Day will review data of AGEN1181 from its ongoing Ph1 dose escalation trial and discuss the initial responses, particularly those in patients with microsatellite stable disease, &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; \u00a0Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Dr. Dhan Chand, Scientific Director Head of Drug Discovery at Agenus, will participate in a webcast hosted by Dr. Matt Phipps of William Blair on Monday, November 16, 2020 at 10:00 a.m. ET. Dr. Steven O\u2019Day will review data of AGEN1181 from its ongoing Ph1 dose escalation trial and discuss the initial responses, particularly those in patients with microsatellite stable disease, &hellip; Continue reading &quot;Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T19:46:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data\",\"datePublished\":\"2020-11-13T19:46:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/\"},\"wordCount\":570,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/\",\"name\":\"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\",\"datePublished\":\"2020-11-13T19:46:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/","og_locale":"en_US","og_type":"article","og_title":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk","og_description":"LEXINGTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; \u00a0Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Steven O\u2019Day, Executive Director of the John Wayne Cancer Institute, Dr. Jennifer Buell, President and COO of Agenus, and Dr. Dhan Chand, Scientific Director Head of Drug Discovery at Agenus, will participate in a webcast hosted by Dr. Matt Phipps of William Blair on Monday, November 16, 2020 at 10:00 a.m. ET. Dr. Steven O\u2019Day will review data of AGEN1181 from its ongoing Ph1 dose escalation trial and discuss the initial responses, particularly those in patients with microsatellite stable disease, &hellip; Continue reading \"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T19:46:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data","datePublished":"2020-11-13T19:46:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/"},"wordCount":570,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/","name":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=","datePublished":"2020-11-13T19:46:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk2OCMzODI2ODcxIzIwMjAwNDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agenus-and-dr-steven-oday-to-participate-in-webcast-hosted-by-william-blair-on-agen1181-and-sitc-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agenus and Dr. Steven O\u2019Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}